Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Andrés Cervantes, R. Adam, Susana Roselló, et al.
Annals of Oncology (2022) Vol. 34, Iss. 1, pp. 10-32
Open Access | Times Cited: 887

Showing 1-25 of 887 citing articles:

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin, et al.
Journal of Clinical Oncology (2023) Vol. 42, Iss. 1, pp. 47-58
Open Access | Times Cited: 343
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Gerald W. Prager, Julien Taı̈eb, Marwan Fakih, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 18, pp. 1657-1667
Closed Access | Times Cited: 221
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero, et al.
The Lancet (2023) Vol. 402, Iss. 10395, pp. 41-53
Closed Access | Times Cited: 142
Therapeutic landscape and future direction of metastatic colorectal cancer
Hideaki Bando, Atsushi Ohtsu, Takayuki Yoshino
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 5, pp. 306-322
Closed Access | Times Cited: 84
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 7, pp. 757-771
Open Access | Times Cited: 73
Stage IV Colorectal Cancer Management and Treatment
Oscar Hernandez Dominguez, Sümeyye Yılmaz, Scott R. Steele
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2072-2072
Open Access | Times Cited: 68
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study
Marwan Fakih, Kanwal Pratap Singh Raghav, David Chang, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101917-101917
Open Access | Times Cited: 54
Colorectal cancer
Cathy Eng, Takayuki Yoshino, Érika Ruiz-García, et al.
The Lancet (2024) Vol. 404, Iss. 10449, pp. 294-310
Closed Access | Times Cited: 51
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer
Kohei Shitara, Kei Muro, Jun Watanabe, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 730-739
Open Access | Times Cited: 33
Mechanisms of metastatic colorectal cancer
Adrià Cañellas‐Socias, Elena Sancho, Eduard Batlle
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 609-625
Closed Access | Times Cited: 30
GPT-4 for Information Retrieval and Comparison of Medical Oncology Guidelines
Dyke Ferber, Isabella C. Wiest, Georg Wölflein, et al.
NEJM AI (2024) Vol. 1, Iss. 6
Closed Access | Times Cited: 28
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial
Robert S. Fichtinger, Luca Aldrighetti, Mohammad Abu Hilal, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 15, pp. 1799-1809
Open Access | Times Cited: 26
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
Akihito Kawazoe, Rui‐Hua Xu, Pilar García‐Alfonso, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 24, pp. 2918-2927
Open Access | Times Cited: 26
Colon and rectal cancer: An emergent public health problem
Marina Pinheiro, David Nascimento Moreira, Michele Ghidini
World Journal of Gastroenterology (2024) Vol. 30, Iss. 7, pp. 644-651
Open Access | Times Cited: 19
Multiparametric MRI for characterization of the tumour microenvironment
Emily Hoffmann, Max Masthoff, Wolfgang G. Kunz, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 428-448
Closed Access | Times Cited: 16
Neoadjuvant treatment of colorectal cancer: comprehensive review
Henry Smith, Per J. Nilsson, Benjamin D. Shogan, et al.
BJS Open (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 16
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver
Javier Ros, Caterina Vaghi, Iosune Baraibar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3304-3304
Open Access | Times Cited: 15
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
Kanwal Raghav, Salvatore Siena, Atsuo Takashima, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 9, pp. 1147-1162
Closed Access | Times Cited: 15
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial
Susan van der Lei, Robbert S. Puijk, Madelon Dijkstra, et al.
The Lancet Oncology (2025)
Closed Access | Times Cited: 11
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
Thierry André, Elena Élez, Heinz‐Josef Lenz, et al.
The Lancet (2025)
Closed Access | Times Cited: 7
A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC)
Pascale Tinguely, Simeon J. S. Ruiter, Jennie Engstrand, et al.
European Journal of Cancer (2023) Vol. 187, pp. 65-76
Open Access | Times Cited: 40
Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review
Nourhan M. Abdelmaksoud, Ahmed I. Abulsoud, Tamer M. Abdelghany, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154509-154509
Closed Access | Times Cited: 40
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
Núria Mulet-Margalef, Jenniffer Linares, Jordi Badia-Ramentol, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1022-1022
Open Access | Times Cited: 32
MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial
Burak Görgec, Ingrid S Hansen, Gunter Kemmerich, et al.
The Lancet Oncology (2023) Vol. 25, Iss. 1, pp. 137-146
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top